# Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes

> **NCT07445334** · NA · NOT_YET_RECRUITING · sponsor: **Western Sydney Local Health District** · enrollment: 40 (estimated)

## Conditions studied

- Premature Ventricular Complexes
- Premature Ventricular Contraction (PVC)
- Premature Ventricular Beats

## Interventions

- **PROCEDURE:** Catheter ablation
- **DRUG:** Medical therapy: Anti-arrhythmic drugs (AAD) and/or beta-adrenergic blocking agents (BB)

## Key facts

- **NCT ID:** NCT07445334
- **Lead sponsor:** Western Sydney Local Health District
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07445334

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07445334, "Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT07445334. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
